Table 3.
Summary of frequently recognized peptides in the study cohort.
| Peptide no. | Region of protein | Amino acid sequence | Subtype B epitopes in subtype C peptide sequence | Parental protein | Study subjects with response (%) |
|---|---|---|---|---|---|
| CD8+ T cell responses | |||||
| 5, 6 | Gag20–30 | RLRPGGKKHYM | WEKIRLRPGGKKKYK, KIRLPGGK, KIRLPGGKKKYKLIRLRPGGKK, RLRPGGKKKY | p17 | 12% |
| 20–23 | Gag78–96 | SLFNTVATLYCVHAGIEVRD | RSLYNTVATLY, SLYNTVATL, NTVATLYCV, TLYCVHQR, TLYCVHQRI, YCVHQRIEIKDTKEAL | p17 | 16% |
| 33–34 | Gag128–138 | GKKVSQNYPIV | QVSQNYPIV, NYPIVQNL | p17–p24 | 8% |
| 45–46 | Gag173–183 | PMFTALSEGAT | AFSPEVIPMFSALSEGATPQ, EVIPMFASALSEGATP, IPMFSALSEGATPQDL | p24 | 8% |
| 51–52 | Gag196–206 | GGHQAAMQMLKD | GHQAAMQMLKE | p24 | 8% |
| 55–57 | Gag212–227 | AAEWDRLHPVHAGPIA | LKETINEEAAEWDRVHPV, AEWDRVHPV, VHPVHAGPIA, HPVHAGPIA | p24 | 16% |
| 59–60 | Gag229–240 | GQMREPRGSDIA | HAGPIAPGQMREPRG, IAPGQMREPRGSDIAGTTST | p24 | 8% |
| 70–71 | Gag271–281 | LGLNKIVRMYS | IYKLWIILGLNKIVRMYSPT, KRWIILGLNKIVRMYSPTSI | p24 | 8% |
| 79–80 | Gag308–318 | RAEQATQDVKN | FKTLRAEQATQDVKNWMTDT | p24 | 8% |
| 87–88 | Gag339–349 | ALGPGASLEEM | KTILRALGPGATLEEMMTAC | p24 | 8% |
| 99–100 | Gag387–397 | SKRIVKCFNCG | SNFKGNKRMVKCFNCGKEGH | p15 | 8% |
| 109–111 | Gag426–439 | DCTERQANFLGKIW | KEGHQMKDCTERQANF, CTERQANFL, TERQANFL, RQANFLGKIWPSYKG, CTERQANFL, FLGKIWPS | p15 | 16% |
| 124–125 | Gag483–493 | PLTSLKSLFGS | KELYPLTSL, TPLSTLRSLF | p15 | 12% |
| CD4+ T cell responses | |||||
| 43–46 | Gag166–183 | AFSPEVIPMFTALSEGAT | AFSPEVIPMFSALSEC | p24 | 8% |
| 62–63 | Gag241–251 | GTTSTLQEQIA | GSDIAGTTSTLQEQIC | p24 | 8% |
| 64–66 | Gag248–262 | EQIAWMTSNPPVPVG | STLQEQIGWMTNNPPIPVGE | p24 | 8% |